Diagnostic testing to identify persons infected with severe acute respiratory syndrome–related
coronavirus 2 (SARS-CoV-2) infection is central to control the global pandemic of COVID-…

Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

Accurate serologic tests to detect host antibodies to severe acute respiratory syndrome–related
coronavirus 2 (SARS-CoV-2) will be critical for the public health response to the …

Background: Administering antimicrobial agents before obtaining blood cultures could
potentially decrease time to treatment and improve outcomes, but it is unclear how this strategy …

Low-resource settings are disproportionately burdened by infectious diseases and
antimicrobial resistance. Good quality clinical bacteriology through a well functioning reference …

Background The genus emmonsia contains three species that are associated with human
disease. Emmonsia crescens and Emmonsia parva are the agents that cause …

Background. Cancer is a known risk factor for developing active tuberculosis. We determined
the incidence and relative risk of active tuberculosis in cancer patients compared to the …

Background Global action plans to tackle antimicrobial resistance (AMR) include
implementation of antimicrobial stewardship (AMS), but few studies have directly addressed the …

Background Persistent digestive disorders account for considerable disease burden in the
tropics. Despite advances in understanding acute gastrointestinal infections, important issues …

Importance Longitudinal mass testing using rapid antigen detection tests (RADT) for serial
screening of asymptomatic persons has been proposed for preventing SARS-CoV-2 …